Response to “Tailored Use of Avacopan in a Case With Refractory Antineutrophil Cytoplasmic Autoantibody-Associated Renal Vasculitis and Concominant Complement System Activation”

Detalles Bibliográficos
Autores principales: van Leeuwen, Jolijn R., Rabelink, Ton J., Teng, Y.K. Onno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Response
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939352/
https://www.ncbi.nlm.nih.gov/pubmed/36815117
http://dx.doi.org/10.1016/j.ekir.2022.11.014
_version_ 1784890831237283840
author van Leeuwen, Jolijn R.
Rabelink, Ton J.
Teng, Y.K. Onno
author_facet van Leeuwen, Jolijn R.
Rabelink, Ton J.
Teng, Y.K. Onno
author_sort van Leeuwen, Jolijn R.
collection PubMed
description
format Online
Article
Text
id pubmed-9939352
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-99393522023-02-21 Response to “Tailored Use of Avacopan in a Case With Refractory Antineutrophil Cytoplasmic Autoantibody-Associated Renal Vasculitis and Concominant Complement System Activation” van Leeuwen, Jolijn R. Rabelink, Ton J. Teng, Y.K. Onno Kidney Int Rep Response Elsevier 2022-11-25 /pmc/articles/PMC9939352/ /pubmed/36815117 http://dx.doi.org/10.1016/j.ekir.2022.11.014 Text en © 2022 International Society of Nephrology. Published by Elsevier Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Response
van Leeuwen, Jolijn R.
Rabelink, Ton J.
Teng, Y.K. Onno
Response to “Tailored Use of Avacopan in a Case With Refractory Antineutrophil Cytoplasmic Autoantibody-Associated Renal Vasculitis and Concominant Complement System Activation”
title Response to “Tailored Use of Avacopan in a Case With Refractory Antineutrophil Cytoplasmic Autoantibody-Associated Renal Vasculitis and Concominant Complement System Activation”
title_full Response to “Tailored Use of Avacopan in a Case With Refractory Antineutrophil Cytoplasmic Autoantibody-Associated Renal Vasculitis and Concominant Complement System Activation”
title_fullStr Response to “Tailored Use of Avacopan in a Case With Refractory Antineutrophil Cytoplasmic Autoantibody-Associated Renal Vasculitis and Concominant Complement System Activation”
title_full_unstemmed Response to “Tailored Use of Avacopan in a Case With Refractory Antineutrophil Cytoplasmic Autoantibody-Associated Renal Vasculitis and Concominant Complement System Activation”
title_short Response to “Tailored Use of Avacopan in a Case With Refractory Antineutrophil Cytoplasmic Autoantibody-Associated Renal Vasculitis and Concominant Complement System Activation”
title_sort response to “tailored use of avacopan in a case with refractory antineutrophil cytoplasmic autoantibody-associated renal vasculitis and concominant complement system activation”
topic Response
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939352/
https://www.ncbi.nlm.nih.gov/pubmed/36815117
http://dx.doi.org/10.1016/j.ekir.2022.11.014
work_keys_str_mv AT vanleeuwenjolijnr responsetotailoreduseofavacopaninacasewithrefractoryantineutrophilcytoplasmicautoantibodyassociatedrenalvasculitisandconcominantcomplementsystemactivation
AT rabelinktonj responsetotailoreduseofavacopaninacasewithrefractoryantineutrophilcytoplasmicautoantibodyassociatedrenalvasculitisandconcominantcomplementsystemactivation
AT tengykonno responsetotailoreduseofavacopaninacasewithrefractoryantineutrophilcytoplasmicautoantibodyassociatedrenalvasculitisandconcominantcomplementsystemactivation

Ejemplares similares